+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06319027

Advanced Imaging Techniques to Improve Assessment of Tumor Activity in Newly Diagnosed Glioblastoma The GABLE Trial

Led by ECOG-ACRIN Cancer Research Group · Updated on 2026-08-18

100

Participants Needed

18

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying newly diagnosed glioblastoma GBM, a type of brain tumor, to see if advanced imaging techniques can provide more detailed and accurate information about tumor activity than the usual MRI scans. This phase II trial focuses on understanding the meaning of changes seen in MRI scans after treatment, since some changes might be due to tumor growth while others may result from treatment effects. The study evaluates biomarkers like dynamic susceptibility contrast MRI, fluciclovine F18 PET, and MR spectroscopy to help distinguish these changes and predict patient outcomes. Participants receive gadolinium-based contrast and undergo DSC-MRI scans at 4 and 8 weeks after completing standard radiation therapy. If disease progression is detected, they will have either MR spectroscopy or a PET scan using fluciclovine F18 within 12 weeks after radiation. After these imaging procedures, participants are monitored with follow-up visits every 8 weeks for one year, then every 12 weeks for up to five years. During the study, patients undergo various imaging scans including DSC-MRI, PET, and MR spectroscopy to assess tumor status. Researchers collect data on overall survival and event-free survival, as well as distinguishing true progression from pseudo-progression on follow-up imaging. Participants clinical and imaging results are tracked over time to evaluate how well the biomarkers predict outcomes. The total monitoring period can last several years to capture long-term results and safety information.

CONDITIONS

Brief Title

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here